Article Excerpt

Pay for performance has emerged as a leading strategy for improving quality and reducing costs in the U.S. healthcare system. As hospitals and other providers sharpen their focus on delivering higher quality care, medical products companies need to understand how these shifts will impact their markets. As companies adapt to the evolving change, the challenge for most will be to transform their selling models to focus on delivering both clinical and economic value in this new and more complex selling environment. ...

Request the Full Article

Click here to request the full article. ZS articles and reports are provided at no cost. A business email address is required to process your request. After receipt of your request, a copy of the article will be emailed to your business email address.

About the Author

Pete Masloski is a Principal with ZS Associates. He is currently the leader of ZS' Medical Products and Services practice.